Ocular inflammatory diseases associated with rheumatoid arthritis

被引:87
作者
Artifoni, Mathieu [1 ]
Rothschild, Pierre-Raphael [2 ]
Brezin, Antoine [2 ]
Guillevin, Loic [1 ]
Puechal, Xavier [1 ]
机构
[1] Univ Paris 05, Hop Cochin, AP HP, Natl Referral Ctr Rare Syst Autoimmune Dis, F-75014 Paris, France
[2] Univ Paris 05, Hop Cochin, AP HP, Dept Opthalmol, F-75014 Paris, France
关键词
PERIPHERAL ULCERATIVE KERATITIS; MYCOPHENOLATE-MOFETIL; NECROTIZING SCLERITIS; DESTRUCTIVE CORNEAL; SJOGRENS-SYNDROME; ANTERIOR UVEITIS; SICCA SYMPTOMS; EYE DISEASE; THERAPY; INFLIXIMAB;
D O I
10.1038/nrrheum.2013.185
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The extra-articular complications of rheumatoid arthritis (RA) include ophthalmological manifestations, which can, in some cases, be the first signs of the disease. These inflammatory ophthalmological conditions include episcleritis, scleritis and peripheral ulcerative keratitis (PUK). RA is the leading cause of necrotizing scleritis and of PUK, which are the two most severe ocular conditions associated with the disease. These conditions can rapidly threaten ocular prognosis and are associated with excess mortality in patients with RA owing to their association with systemic vasculitis. Close collaboration between the ophthalmologist and the rheumatologist or internal medicine expert is required for the diagnosis and therapeutic management of these patients. In this Review, we provide an overview of ocular inflammatory diseases in patients with RA with particular focus on the diagnosis and current available therapies (including biologic agents) for these conditions. Furthermore, we propose a decision tree to assist clinicians in their choice of treatment for patients with RA who also have ocular inflammatory disease.
引用
收藏
页码:108 / 116
页数:9
相关论文
共 69 条
[1]   Evaluation of patients with scleritis for systemic disease [J].
Akpek, EK ;
Thorne, JE ;
Qazi, FA ;
Do, DV ;
Jabs, DA .
OPHTHALMOLOGY, 2004, 111 (03) :501-506
[2]   Treatment of Sjogren's Syndrome-Associated Dry Eye [J].
Akpek, Esen Karamursel ;
Lindsley, Kristina B. ;
Adyanthaya, Rohit S. ;
Swamy, Ramya ;
Baer, Alan N. ;
McDonnell, Peter J. .
OPHTHALMOLOGY, 2011, 118 (07) :1242-1252
[3]  
Albert M., 2011, Arch Soc Esp Oftalmol, V86, P118, DOI 10.1016/j.oftal.2011.01.003
[4]  
ANDONOPOULOS AP, 1987, J RHEUMATOL, V14, P1098
[5]   Stabilization of Bilateral Progressive Rheumatoid Corneal Melt with Infliximab [J].
Antao, Sheelah F. ;
Ayoub, Tariq ;
Tahir, Hasan ;
Parmar, Dipak N. .
CASE REPORTS IN OPHTHALMOLOGICAL MEDICINE, 2012, 2012
[6]  
Antero DC, 2011, REV ASSOC MED BRAS, V57, P318
[7]   Necrotizing scleritis associated with rheumatoid arthritis: long-term remission with high-dose infliximab therapy [J].
Ashok, D ;
Ayliffe, WH ;
Kiely, PDW .
RHEUMATOLOGY, 2005, 44 (07) :950-951
[8]   Rheumatoid arthritis-associated necrotizing scleritis and peripheral ulcerative keratitis treated successfully with infliximab [J].
Atchia, Ismael I. ;
Kidd, C. Elizabeth ;
Bell, R. W. D. .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2006, 12 (06) :291-293
[9]   CELLS PERPETUATING THE INFLAMMATORY RESPONSE IN SCLERITIS [J].
BERNAUER, W ;
WATSON, PG ;
DAICKER, B ;
LIGHTMAN, S .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1994, 78 (05) :381-385
[10]   Efficacy of the IL-1 receptor antagonist, anakinra, for the treatment of diffuse anterior scleritis in rheumatoid arthritis. Report of two cases [J].
Botsios, C. ;
Sfriso, P. ;
Ostuni, P. A. ;
Todesco, S. ;
Punzi, L. .
RHEUMATOLOGY, 2007, 46 (06) :1042-1043